Endeavor

CAR T Therapy Safe for Older Patients

Moffitt’s closer look at clinical trial data could expand therapy’s use and effectiveness.

Treating Gynecologic Cancers With Immunotherapy

Physicians and researchers are combining efforts to explore ways to harness the body’s immune system to better fight gynecologic cancers.

Immunotherapy May Boost Survival in Recurrent Ovarian Cancer

Combination chemotherapy and immunotherapy treatment shows promise in recent study.

FDA Approves First Immunotherapy for Breast Cancer

Patients with an aggressive form of breast cancer now have another weapon in their arsenal to fight the disease.

The Monkees’ Peter Tork Had Rare Tongue Cancer

The Monkees’ bassist passed away this week. He also had a rare form of tongue cancer.

Nearly 40 Percent of CAR T Patients Remain in Remission

Many ZUMA-1 participants remain in remission and more than half of those treated remain alive.

New Study Shows CAR T-cell Therapy for Lymphoma Lives up to its Press

Seventeen cancer centers compare real world outcomes of diffuse large B cell lymphoma patients treated with Yescarta® to ZUMA-1 clinical trial data

Moffitt Honors CAR T Patient during Veterans Day Ceremony

Moffitt honored Floyd Cook, other veterans during the annual flag-raising ceremony.

Is Immunotherapy the Key to Fighting Ovarian Cancer?

Oncologists believe immunotherapy could be the missing piece of the puzzle.